Both in Biotechnology
Inhibikase Therapeutics vs Protalix BioTherapeutics
Over the past year IKT returned 0.0% and PLX returned +13.8%; their daily moves had a correlation of 0.24.
IKT 0.0% PLX +13.8%Growth of $1, one year, split-adjusted
| Metric | IKT | PLX |
|---|---|---|
| Price | $1.48 | $2.61 |
| Market cap | $206.5M | $210.3M |
| Today | −3.90% | +1.95% |
| 1 month | −26.0% | −3.7% |
| 6 months | −23.3% | +33.2% |
| Year to date | −27.8% | +45.0% |
| 1 year | +0.7% | +10.1% |
| Revenue growth (YoY) | — | +27.1% |
| Gross margin | — | 61.0% |
| Net margin | — | 19.0% |
| P/E (TTM) | — | 11.1× |
| Price / sales | — | 2.6× |
| Net cash | $159.0M | $40.7M |
| Dividend yield | — | — |
| Volatility (60d) | 50.9% | 44.8% |
| Short % of float | 17.8% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).